The report offers insights and in-depth analysis of the intravascular ultrasound (IVUS) devices market concerning various parameters such as market trends and opportunities, market dynamics, and competitive landscape analysis of leading market players across North America, Europe, Asia-Pacific, South and Central America, and Middle East & Africa. It also includes the impact analysis of the COVID-19 pandemic across the regions.
CVDs continue to be the most significant cause of morbidity and mortality worldwide. An unhealthy diet is the most crucial lifestyle factor that leads to CVDs. According to the WHO, CVDs are one of the causes of death accounting for nearly 17.9 million deaths worldwide in 2019.
A few of the primary risk factors of CVDs include family history, ethnicity, age, and other risk factors: tobacco consumption, hypertension, obesity, high cholesterol, physical inactivity, diabetes, unhealthy diets, and alcohol consumption. The majority of CVDs can be prevented through pre-monitoring and pre-diagnosis using intravascular ultrasound devices. Therefore, the growing number of CVDs is propelling the demand for intravascular ultrasound devices.
Due to the COVID-19 pandemic, the demand for intravascular ultrasound (IVUS) devices has increased. The intravascular ultrasound (IVUS) devices market in Asia Pacific is likely to expand at a rapid pace in the near future. This expansion can be majorly attributed to the availability of trained and well-qualified technicians and rise in adoption of technologically advanced diagnostic equipment.
Based on modality, the intravascular ultrasound (IVUS) devices market is segmented into virtual histology IVUS, iMap IVUS, and integrated backscatter IVUS. In 2021, virtual histology IVUS segment held a larger market share. However, the iMap IVUS segment is estimated to register a higher CAGR of 8.0% during the forecast period.
The regional trends and factors influencing the Intravascular Ultrasound (IVUS) Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Intravascular Ultrasound (IVUS) Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 608.97 Million |
| Market Size by 2028 | US$ 1,012.37 Million |
| Global CAGR (2021 - 2028) | 7.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Intravascular Ultrasound (IVUS) Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Intravascular Ultrasound (IVUS) Devices Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
Based on type, the intravascular ultrasound (IVUS) devices market is segmented into equipment and accessories. In 2021, the accessories segment held a larger market share, and the same segment is estimated to register a higher CAGR of 7.7% in the market during the forecast period
Based on end user, the intravascular ultrasound (IVUS) devices market is segmented into hospitals and clinics, diagnostic centers, and academic and research institutes. In 2021, hospitals and clinics segment held a larger market share. However, the diagnostic centers segment is estimated to register a higher CAGR of 7.9% during the forecast period
Companies commonly adopt inorganic strategies such as mergers and acquisitions to cater to changing customer demands and maintain their brand names worldwide. Players operating in the intravascular ultrasound (IVUS) devices market also adopt organic strategies, such as product launch and expansion, to outstretch their footprint and product portfolio worldwide and meet the growing demand.
Koninklijke Philips N.V.; GE Healthcare; Siemens AG; Boston Scientific Corporation; Infraredx, INC.; Terumo Corporation; Axle International; Conavi Medical Inc.; Canon Medical Systems; Abbott, and ACIST Medical System are among the leading companies operating in the high throughput screening market.
The market is estimated to grow with a CAGR of 7.5% from 2021 to 2028.
Key factors such as the high prevalence of coronary artery diseases coupled with the increasing focus of numerous countries on building robust healthcare infrastructure will contribute to the expansion of the intravascular ultrasound devices market.
Intravascular Ultrasound (IVUS) is a catheter-based diagnostic technique used to diagnose and treat both arteries and veins. Ultrasound does not use or produce any ionizing radiation, has no known harmful effects, and can provide clear images of soft tissues that are not well seen on x-ray images.